PREVALENCE OF HEPATITIS C VIRUS INFECTION AMONG BLOOD DONORS AT A TERTIARY CARE CENTRE: A RETROSPECTIVE STUDY

Authors

  • Vinit Bhatnagar
  • Dr. Jyoti Tomar

DOI:

https://doi.org/10.53555/7rgkcw41

Keywords:

Hepatitis C virus, Blood donors, Seroprevalence, ELISA, Transfusion-transmitted infections

Abstract

Background: Hepatitis C virus (HCV) infection is a major transfusion-transmitted infection and a global public health challenge. Despite mandatory screening of blood donors, periodic surveillance remains essential to ensure transfusion safety.
Objectives: To determine the seroprevalence of HCV infection among blood donors at a tertiary care centre and to analyse year-wise trends.
Materials and Methods: A retrospective, record-based study was conducted in the blood bank of a tertiary care teaching hospital. Blood donor records from January 2021 to December 2025 were reviewed. All donated blood units were screened for anti-HCV antibodies using a third-generation enzyme-linked immunosorbent assay (ELISA). Data were analysed to calculate prevalence and trends.
Results: A total of 11,820 blood donations were screened during the study period. Six donors were found to be reactive for anti-HCV antibodies, yielding an overall seroprevalence of 0.05%. No reactive cases were observed in 2021 and 2023, while one reactive donor each was identified in 2022 and 2024, and four reactive donors were detected in 2025.
Conclusion:
The study demonstrates a low prevalence of HCV infection among blood donors, reflecting effective donor selection and screening practices. Continuous surveillance is necessary to maintain and improve transfusion safety.

 

Author Biographies

  • Vinit Bhatnagar

    Research Scholar, Department of Microbiology, Sai Tirupati University, Udaipur, Rajasthan, India Email: [email protected]

  • Dr. Jyoti Tomar

    Research Supervisor Department of Microbiology, Sai Tirupati University, Udaipur, Rajasthan, India

References

1. Makroo RN, Hegde V, Chowdhry M, Bhatia A, Rosamma NL. Seroprevalence of infectious markers and their trends in blood donors in a hospital-based blood bank in North India. Indian J Med Res. 2015;142(3):317-322.

2. Pahuja S, Sharma M, Baitha B, Jain M. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in blood donors in Delhi. Asian J Transfus Sci. 2010;4(2):72-74.

3. Gupta PK, Kumar H, Basannar DR, Jaiprakash M. Transfusion transmitted infections in arWorld Health Organization. Global hepatitis report 2017. Geneva: World Health Organization; 2017.

med forces: Prevalence and trends. Med J Armed Forces India. 2006;62(4):348-350.

4. Chandra T, Kumar A, Gupta A. Prevalence of transfusion transmitted infections in blood donors: An Indian experience. Trop Doct. 2009;39(3):152-154.

5. Anand AC, Dhiman RK, Hari S, et al. Hepatitis C virus infection in India: Challenges and successes. J Clin Exp Hepatol. 2021;11(3):302-312.

6. Singh B, Verma M, Verma K. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends. Jpn J Infect Dis. 2004 Apr;57(2):49-51. PMID: 15118208.

Downloads

Published

2026-01-21

How to Cite

Vinit Bhatnagar, & Dr. Jyoti Tomar. (2026). PREVALENCE OF HEPATITIS C VIRUS INFECTION AMONG BLOOD DONORS AT A TERTIARY CARE CENTRE: A RETROSPECTIVE STUDY. Journal of Population Therapeutics and Clinical Pharmacology, 33(1), 154-157. https://doi.org/10.53555/7rgkcw41
More Citation Formats

Issue

Section

Articles

How to Cite

Vinit Bhatnagar, & Dr. Jyoti Tomar. (2026). PREVALENCE OF HEPATITIS C VIRUS INFECTION AMONG BLOOD DONORS AT A TERTIARY CARE CENTRE: A RETROSPECTIVE STUDY. Journal of Population Therapeutics and Clinical Pharmacology, 33(1), 154-157. https://doi.org/10.53555/7rgkcw41